Ismail kola biography

Adelaide, Australia, 25 May – GPN Vaccines is pleased to announce Dr Ismail Kola has joined the Company’s Board of Directors.

Dr Kola is a Senior Partner at Forepont Capital, a New York-based venture capital firm investing in pharmaceutical and biotechnology companies that improve healthcare outcomes.

Prior to this, Ismail held several senior executive positions in the pharmaceutical industry including Chief Scientific Officer, President of New Medicines and Executive Committee Member at UCB Pharmaceuticals; Senior Vice President and Head of Discovery Research, Early Clinical Research & Experimental Medicine at Schering-Plough; Senior Vice President Basic Research and Site Head Rahway at Merck (known as MSD outside the USA) and Vice President and Global Head Genomics Science and Biotechnology at Pharmacia Corporation.

Throughout Ismail’s distinguished year career in the pharmaceutical industry, he has led teams that have